Table 1.
Demographic and Clinical Characteristics of Patients Infected With a Local Maryland Variant
| Demographic and Clinical Characteristics | Patients, No. (%)a (n = 44) |
|---|---|
| Age, median (range), y | 49 (1.2–84) |
| No. (%) of | |
| Sex | |
| Male | 18 (40.9) |
| Female | 26 (59.1) |
| Comorbid conditions (n = 34)b | |
| Total | 19/34 (55.9) |
| Obesity (BMI, >30c) | 7 (20.6) |
| Hypertension | 10 (29.4) |
| Cardiovascular disease | 4 (11.7) |
| Diabetes | 2 (5.9) |
| Asthma/allergic rhinitis | 4 (11.8) |
| Transplant recipient | 1 (2.9) |
| Admission status (basis for severity index) | |
| Outpatient | 40 (90.9) |
| Inpatient | 4 (9.1) |
| ICU | 1 (2.3) |
| Admission status by age | |
| ≤40 y | 17 (100) |
| >40–55 y | |
| Outpatient | 12 (92.3) |
| Inpatient | 1 (7.7) |
| >55 y | |
| Outpatient | 11 (78.6) |
| Inpatient | 3 (21.4) |
| ICU | 1 (7.1) |
| Positive after COVID-19 vaccine | 4 (9.1)d |
| Travel history | 0 (0) |
Abbreviations: BMI, body mass index; COVID-19, coronavirus disease 2019; ICU, intensive care unit.
aData represent no. (%) of patients unless otherwise specified.
bInformation on comorbid conditions was not available for 10 patients.
cBMI was calculated as weight in kilograms divided by height in meters squared.
dPositive results occurred 3 days after the first vaccine dose in 2 patients, 7 days after the first dose in 1, and 3 weeks after the first dose in 1.